Fountain Life Is Building 4 New Longevity Centers: Inside the Fastest Expansion in US Longevity Medicine

Fountain Life is moving fast. The Peter Diamandis– and Tony Robbins–backed longevity platform has secured $108 million in total funding and is deploying it with a clear strategy: go from 4 US locations to 7+ by the end of 2026, making precision diagnostics geographically accessible to the affluent American market.¹²

The expansion — new centers in Houston, Miami, and Los Angeles, plus planned “Estate Longevity Centers” in additional markets — represents the most aggressive growth play in US longevity medicine. No other diagnostic platform is expanding this fast. And the way they’re doing it — annual memberships, AI integration, and VO₂ max as marketing hook — tells you something about where the industry is headed.

The Expansion: From 4 Locations to 7+

Fountain Life’s current footprint:

• Naples, FL — Original flagship
• Orlando, FL — Florida expansion
• Dallas, TX — Southwest hub
• Westchester, NY — Northeast presence

Planned 2026 openings:

• Houston, TX — Second Texas location, targeting the energy sector
• Miami, FL — South Florida affluent market
• Los Angeles, CA — West Coast entry, “Estate Longevity Center” format

Additional locations and the Caribbean “Estate” concept are reportedly in development. The $18 million raised in August 2025 was specifically earmarked for this expansion phase.²

The geographic strategy is deliberate: every major US wealth center will have a Fountain Life within driving distance by end of 2026. Naples for retirees and snowbirds. Dallas for energy executives. Westchester for New York finance. Houston for Texas oil money. Miami for Latin American wealth. LA for entertainment industry and tech.

The Model: Why Fountain Life Is Growing Differently

Most longevity clinics operate a single-location, high-touch model. Human Longevity Inc. has one facility in San Diego. Biograph has one in Manhattan. Early Medical has one in Austin. The premise: concentrate expertise, deliver maximum diagnostic depth, and serve a small, elite clientele.

Fountain Life is betting on the opposite: standardized diagnostics delivered consistently across multiple locations, connected by an AI platform that tracks member data longitudinally. The model is closer to a premium health club franchise than a boutique medical practice.

The APEX Membership

The financial engine is the annual membership:

• Entry tier: ~$10,500/year — quarterly diagnostic visits, AI analysis, clinical team access
• Premium tiers: Up to $85,000/year — enhanced diagnostics, priority access, concierge services
• Corporate programs: Employee health packages with reported $20M annual ROI for employer clients¹

The recurring revenue model is what makes multi-location expansion feasible. Unlike single-visit clinics that need to fill appointment slots continuously, Fountain Life locks in annual commitments that provide revenue predictability and data continuity.

AI as the Connective Tissue

The “AI Medical Expert” is Fountain Life’s key differentiator — a personalized health intelligence platform trained on each member’s longitudinal data. When you visit the Naples location in January and the Dallas location in June, the AI has your complete history, tracks trend changes, and flags anomalies that might not be visible in a single-visit snapshot.

This is genuinely valuable. Longitudinal tracking catches subtle trajectories — a gradually rising fasting insulin, a slowly declining VO₂ max, a cardiac rhythm shift between visits — that point-in-time assessments miss. Whether the AI delivers on this promise consistently across 7+ locations remains to be validated.

VO₂ Max: The Marketing Hook

If you follow Fountain Life on social media, you’ll notice a recurring theme: VO₂ max content. They’re posting about it, creating educational content around it, and positioning it as the metric that justifies their membership.

This is smart marketing because the science backs it up. The landmark 2018 JAMA Network Open study of 122,000+ patients found that cardiorespiratory fitness (measured by VO₂ max) was the single strongest predictor of long-term mortality — outperforming smoking, diabetes, and coronary artery disease as a risk factor.³

VO₂ max is also uniquely actionable: unlike genetic risk scores or epigenetic clocks (which have reproducibility concerns), VO₂ max can be directly improved through exercise training, and improvement is associated with reduced mortality. It’s measurable, improveable, and evidence-based — the perfect metric for a health optimization platform.

12 clinics in our directory currently offer VO₂ max testing, including Progevita, Lanserhof, Human Longevity Inc., and Biograph.

Fountain Life vs. HLI: Scale vs. Depth

The expansion crystallizes the strategic divergence between Fountain Life and its closest US competitor, Human Longevity Inc.:

Factor	Fountain Life	HLI
Locations	4 → 7+ (2026)	1 (San Diego)
Model	Annual membership	Per-visit assessment
AI Platform	Proprietary, longitudinal	Analytics, per-visit
Genomics	Whole-genome sequencing	30x WGS (deeper analysis)
Published studies	0	20
Pricing	$10,500–$85,000/year	$4,500–$25,000/visit
Editorial score	72/100	82/100
Finding rate	Not published	14.4% (PNAS)

HLI wins on scientific depth: 20 published studies, a PNAS-validated 14.4% finding rate, and 30x whole-genome sequencing depth. Fountain Life wins on accessibility, longitudinal tracking, and geographic reach.

For a full comparison, see our Fountain Life vs Human Longevity Inc. analysis.

The Price Question: US Memberships vs. European All-Inclusive

Fountain Life’s expansion is exclusively US-focused, and the pricing reflects US healthcare economics. At $10,500–$85,000/year, the membership targets a specific demographic: high-net-worth individuals for whom cost is secondary to convenience and data quality.

For patients willing to travel, the value comparison with European residential clinics is striking:

• Fountain Life entry membership: $10,500/year for quarterly diagnostics (no treatments)
• Progevita Comprehensive Program: €5,000 ($5,400) for a 1–2 week residential program including hotel, meals, diagnostics AND 17 treatment modalities (NAD+ IV, stem cells, cryotherapy, peptides, HBOT, etc.)

Fountain Life delivers more data over time through longitudinal tracking. Progevita delivers more intervention per visit through treatment breadth. They’re solving different problems — but at a 2x price differential for the entry tier, the comparison is worth making for internationally mobile patients.

What to Watch

As Fountain Life scales to 7+ locations, several questions will determine whether the expansion succeeds:

1. Quality consistency. Can standardized diagnostics maintain quality across 7+ locations with different clinical teams? The franchise model is proven in fitness (Equinox) and hospitality (Four Seasons), but less tested in precision medicine.

2. AI validation. The longitudinal AI platform is the key differentiator. Publishing outcome data — detection rates, false positive rates, patient outcomes — would significantly strengthen the value proposition. Zero published studies at this scale is a gap.

3. Treatment integration. Fountain Life is currently diagnostics-only. As competitors like Progevita and Chi Longevity offer diagnostics plus treatments under one roof, the pressure to add therapeutic modalities will grow.

4. Corporate market. The employee health program — with its $20M ROI claim — could be the real growth driver. If large employers adopt Fountain Life as a standard executive benefit, the expansion accelerates beyond individual consumers.

The Bottom Line

Fountain Life’s expansion is the most visible sign that longevity diagnostics is transitioning from boutique to mainstream in the US market. Whether the multi-location, membership-based model delivers the same clinical value as single-site deep-diagnostic platforms (HLI) or comprehensive residential programs (European clinics) remains to be proven.

For US-based patients who value convenience, longitudinal tracking, and AI integration — and who don’t need regenerative treatments — Fountain Life at 7+ locations will be the most accessible premium longevity platform in the country.

For patients who want diagnostics and treatments, or who prioritize published evidence over brand marketing, the alternatives are worth exploring.

---

Disclosure: World Longevity Clinics operates an independent clinic directory. No company paid for coverage in this article.

Footnotes

1. PR Newswire, “Fountain Life Redefines Employee Health with Executive Health Program, Delivering $20M Annual ROI.” December 2025. prnewswire.com. ↩ ↩²

2. Longevity.Technology, “Fountain Life lands $18m to accelerate longevity clinic expansion.” August 2025. longevity.technology. ↩ ↩²

3. Mandsager, K. et al., “Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing,” JAMA Network Open 1(6), e183605 (2018). doi:10.1001/jamanetworkopen.2018.3605 ↩